Haibo Yu
Guangzhou University of Chinese Medicine(CN)North China Electric Power University(CN)Okayama University(JP)Zhengzhou University(CN)Wenzhou Central Hospital(CN)First Affiliated Hospital of Jiamusi University(CN)Second Hospital of Tianjin Medical University(CN)Zhengzhou People's Hospital(CN)Shenzhen Pingle Orthopedic Hospital(CN)Fourth People's Hospital of Shenzhen(CN)Tianjin Medical University(CN)Harbin Veterinary Research Institute(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Pancreatic function and diabetes, Circular RNAs in diseases, Diabetes and associated disorders
Most-Cited Works
- → The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer(2016)228 cited
- → Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx(2020)117 cited
- → Little to no expression of angiotensin‐converting enzyme‐2 on most human peripheral blood immune cells but highly expressed on tissue macrophages(2020)115 cited
- → PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway(2019)113 cited
- → SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3‐9 homolog 1 and SET domain containing 1A histone methyltransferases(2018)96 cited
- → An in silicoanalysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma(2012)